Boston Trust Walden Corp Cuts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Posted by Defense World Staff on Mar 30th, 2023

Boston Trust Walden Corp lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 17.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,514 shares of the medical equipment provider’s stock after selling 4,382 shares during the quarter. Boston Trust Walden Corp’s holdings in Intuitive Surgical were worth $5,443,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of ISRG. MADDEN SECURITIES Corp acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. Evermay Wealth Management LLC raised its position in Intuitive Surgical by 103.4% during the fourth quarter. Evermay Wealth Management LLC now owns 118 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 60 shares during the period. MinichMacGregor Wealth Management LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at $35,000. Fiduciary Alliance LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $38,000. Finally, Bogart Wealth LLC increased its stake in shares of Intuitive Surgical by 70.1% during the third quarter. Bogart Wealth LLC now owns 148 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 61 shares in the last quarter. 81.96% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

ISRG stock opened at $250.76 on Thursday. The firm has a market cap of $87.83 billion, a PE ratio of 68.51, a PEG ratio of 5.15 and a beta of 1.29. Intuitive Surgical, Inc. has a one year low of $180.07 and a one year high of $308.97. The firm’s 50 day moving average price is $242.03 and its 200-day moving average price is $240.56.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its earnings results on Tuesday, January 24th. The medical equipment provider reported $1.23 EPS for the quarter, missing analysts’ consensus estimates of $1.25 by ($0.02). The business had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.66 billion. Intuitive Surgical had a net margin of 21.25% and a return on equity of 11.27%. Intuitive Surgical’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.30 EPS. Equities research analysts predict that Intuitive Surgical, Inc. will post 4.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research analyst reports. BTIG Research lowered their price objective on Intuitive Surgical from $316.00 to $279.00 and set a “buy” rating on the stock in a report on Wednesday, January 25th. Wells Fargo & Company dropped their price target on Intuitive Surgical from $305.00 to $289.00 and set an “overweight” rating for the company in a research report on Wednesday, January 25th. UBS Group began coverage on Intuitive Surgical in a report on Tuesday. They issued a “neutral” rating and a $278.00 price objective on the stock. Barclays lifted their target price on shares of Intuitive Surgical from $235.00 to $298.00 in a research note on Wednesday, January 4th. Finally, StockNews.com assumed coverage on shares of Intuitive Surgical in a research report on Thursday, March 16th. They issued a “hold” rating for the company. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $270.39.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP David J. Rosa sold 45,025 shares of the business’s stock in a transaction that occurred on Monday, February 6th. The shares were sold at an average price of $250.53, for a total value of $11,280,113.25. Following the sale, the executive vice president now directly owns 125,385 shares of the company’s stock, valued at approximately $31,412,704.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, EVP David J. Rosa sold 45,025 shares of Intuitive Surgical stock in a transaction on Monday, February 6th. The stock was sold at an average price of $250.53, for a total value of $11,280,113.25. Following the completion of the sale, the executive vice president now directly owns 125,385 shares of the company’s stock, valued at $31,412,704.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 1,629 shares of the business’s stock in a transaction on Friday, January 27th. The shares were sold at an average price of $250.00, for a total value of $407,250.00. Following the completion of the sale, the executive vice president now owns 6,769 shares in the company, valued at approximately $1,692,250. The disclosure for this sale can be found here. Insiders have sold 82,396 shares of company stock valued at $20,438,478 over the last 90 days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

(Get Rating)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.